Anti-Ischemic Effect of a Novel Cardioprotective Agent, JTV519, Is Mediated Through Specific Activation of δ-Isoform of Protein Kinase C in Rat Ventricular Myocardium
Author(s) -
Koichi Inagaki,
Yasuki Kihara,
Wataru Hayashida,
Toshiaki Izumi,
Yoshitaka Iwanaga,
Takeshi Yoneda,
Yuzo Takeuchi,
Katsuo Suyama,
Eri Muso,
Shigetake Sasayama
Publication year - 2000
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.101.7.797
Subject(s) - medicine , cardioprotection , creatine kinase , protein kinase c , ischemia , lactate dehydrogenase , gene isoform , reperfusion injury , pharmacology , cardiology , ischemic preconditioning , ventricular pressure , myocyte , kinase , enzyme , microbiology and biotechnology , biochemistry , hemodynamics , biology , gene
A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury. We investigated the effect of JTV519 on ischemia/reperfusion injury in isolated rat hearts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom